This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovator Manoj Maniram Singh Kushwaha: Pioneering Advances in Diabetes Treatment
Introduction
Manoj Maniram Singh Kushwaha, based in Thane, India, is a noted inventor who has contributed significantly to the field of pharmaceuticals with his innovative ideas. With one patent to his name, he is recognized for his development of Mumbaistatin, a compound that represents a potential breakthrough in diabetes treatment.
Latest Patents
Kushwaha's noteworthy patent revolves around Mumbaistatin, which is described as a glucose-6-phosphate translocase inhibitor. This compound is not only significant in its chemical composition but also in its practical application. Mumbaistatin is derived from the microorganism HIL-008003 (DSM 11641) and is aimed at addressing the critical health issue of diabetes mellitus. The patent outlines both the process of production and its use in creating pharmaceuticals intended for treating this prevalent condition.
Career Highlights
Manoj Kushwaha is associated with Aventis Pharma Deutschland GmbH, a company renowned for its impactful contributions to the pharmaceutical industry. His role at this esteemed organization has allowed him to further his research and development efforts, paving the way for new medical solutions to enhance patient care and improve health outcomes.
Collaborations
Throughout his career, Kushwaha has collaborated with notable professionals such as Nirogi Venkata Satya Ramakrishna and Keshavapura Hosamane Sreedhara Swamy. These partnerships have facilitated a dynamic exchange of ideas and expertise, contributing to the success and depth of his innovative projects.
Conclusion
Manoj Maniram Singh Kushwaha stands out as a dedicated inventor making strides in the pharmaceutical domain. His creation of Mumbaistatin demonstrates not only his ingenuity but also his commitment to improving health standards for individuals with diabetes mellitus. With a promising patent and valuable collaborations, Kushwaha’s contributions will likely leave a lasting impact on medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile